ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

72.49

-3.80 (-4.98%)

At close: Mar 12, 2026, 4:00 PM EDT

72.50

+0.01 (0.01%)

After-hours: Mar 12, 2026, 4:10 PM EDT

ANI Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	883.37	614.38	486.82	316.39	216.14
Revenue Growth (YoY)	43.78%	26.20%	53.87%	46.38%	3.67%
Cost of Revenue	341.31	250.21	181.51	138.79	100.61
Gross Profit	542.06	364.17	305.3	177.6	115.53
Selling, General & Admin	317.75	249.64	161.7	124.04	84.29
Depreciation & Amortization Expenses	91.42	67.73	59.79	56.97	47.25
Research & Development	51.66	44.58	34.29	22.32	11.37
Other Operating Expenses	-29.86	12.33	2.56	9.55	12.4
Total Operating Expenses	430.96	374.28	258.33	212.88	155.32
Operating Income	111.09	0.58	46.97	-35.28	-39.79
Interest Expense	-20.06	-17.6	-26.94	-28.05	-11.92
Other Non-Operating Income (Expense)	4.76	-16.85	-0.16	0.67	-4.34
Total Non-Operating Income (Expense)	-15.3	-34.45	-27.1	-27.38	-16.27
Pretax Income	95.79	-22.21	19.87	-62.67	-56.06
Provision for Income Taxes	17.45	-3.69	1.09	-14.77	-13.46
Net Income	77.18	-18.52	18.78	-47.9	-42.6
Net Income Attributable to Preferred Dividends	1.16	-	-	-	-
Net Income to Common	77.18	-18.52	18.78	-47.9	-42.6
Shares Outstanding (Basic)	20	19	18	16	13
Shares Outstanding (Diluted)	21	19	18	16	13
Shares Change (YoY)	9.89%	6.18%	11.89%	29.77%	4.73%
EPS (Basic)	3.50	-1.04	0.86	-3.05	-3.40
EPS (Diluted)	3.32	-1.04	0.85	-3.05	-3.40
Free Cash Flow	0	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	-	-56.60%	-	-	-91.62%
Free Cash Flow Per Share	-	2.47	6.05	-2.46	-
Gross Margin	61.36%	59.27%	62.71%	56.13%	53.45%
Operating Margin	12.58%	0.10%	9.65%	-11.15%	-18.41%
Profit Margin	8.87%	-3.01%	3.86%	-15.14%	-19.71%
FCF Margin	0.00%	7.78%	22.61%	-12.67%	0.35%
EBITDA	111.09	68.32	106.76	24.37	7.46
EBITDA Margin	12.58%	11.12%	21.93%	7.70%	3.45%
EBIT	111.09	0.58	46.97	-35.28	-39.79
EBIT Margin	12.58%	0.10%	9.65%	-11.15%	-18.41%
Effective Tax Rate	18.22%	16.61%	5.50%	23.57%	24.00%

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q